methylmercuric chloride has been researched along with Autoimmune Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auger, C; Chakrabarti, S; Lamontagne, L; Massicotte, E; Pheng, SR | 1 |
| Björn, E; Häggqvist, B; Havarinasab, S; Hultman, P | 1 |
2 other study(ies) available for methylmercuric chloride and Autoimmune Disease
| Article | Year |
|---|---|
Sensitivity to methylmercury-induced autoimmune disease in mice correlates with resistance to apoptosis of activated CD4+ lymphocytes.
Topics: Animals; Apoptosis; Autoimmune Diseases; CD4-Positive T-Lymphocytes; Concanavalin A; Fas Ligand Protein; fas Receptor; Female; Flow Cytometry; Membrane Glycoproteins; Methylmercury Compounds; Mice; Mice, Inbred C57BL; Spleen | 2003 |
The immunosuppressive effect of methylmercury does not preclude development of autoimmunity in genetically susceptible mice.
Topics: Animals; Antibodies, Antinuclear; Antigen-Antibody Complex; Autoimmune Diseases; B-Lymphocytes; Cell Count; Cytokines; Dose-Response Relationship, Drug; Environmental Pollutants; Genetic Predisposition to Disease; Immunoglobulins; Immunosuppressive Agents; Lymph Nodes; Methylmercury Compounds; Mice; Pilot Projects; Spleen; Syndrome; T-Lymphocytes | 2005 |